Trial Profile

AXIS 2: AX200 for the Treatment of Ischemic Stroke - A Multinational, Multicenter, Randomized, Doubleblind, Placebo-Controlled Phase II Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 03 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Mar 2021 Results (n=259) of retrospective study assessing association of these imaging markers with functional outcome after acute ischemic stroke from patients enrolled in the AXIS-2 trial presented at the International Stroke Conference 2021
28 Jan 2021 Results(n=259) of post hoc, exploratory and retrospective analysis , investigating association between imaging markers of brain frailty with functional outcome after acute ischemic stroke, published in the Stroke
14 Apr 2012 Planned number of patients changed from 328 to 350 as reported by European Clinical Trials Database.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com